Dabrafenib plus trametinib in patients with BRAF V600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
Titel:
Dabrafenib plus trametinib in patients with BRAF V600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
Auteur:
Wen, Patrick Y Stein, Alexander van den Bent, Martin De Greve, Jacques Wick, Antje de Vos, Filip Y F L von Bubnoff, Nikolas van Linde, Myra E Lai, Albert Prager, Gerald W Campone, Mario Fasolo, Angelica Lopez-Martin, Jose A Kim, Tae Min Mason, Warren P Hofheinz, Ralf-Dieter Blay, Jean-Yves Cho, Daniel C Gazzah, Anas Pouessel, Damien Yachnin, Jeffrey Boran, Aislyn Burgess, Paul Ilankumaran, Palanichamy Gasal, Eduard Subbiah, Vivek